Reckitt Benckiser Group plc (LON:RKT - Get Free Report) shares rose 1.5% on Tuesday . The company traded as high as GBX 4,773 ($63.32) and last traded at GBX 4,754 ($63.07). Approximately 726,243 shares were traded during trading, a decline of 86% from the average daily volume of 5,240,369 shares. The stock had previously closed at GBX 4,684 ($62.14).
Reckitt Benckiser Group Stock Performance
The stock has a market capitalization of £33.95 billion, a price-to-earnings ratio of 22.77, a PEG ratio of 1.10 and a beta of 0.09. The company's 50-day simple moving average is GBX 5,048.97 and its 200-day simple moving average is GBX 4,974.22. The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26.
Reckitt Benckiser Group (LON:RKT - Get Free Report) last announced its earnings results on Thursday, March 6th. The company reported GBX 349.70 ($4.64) earnings per share (EPS) for the quarter. Reckitt Benckiser Group had a return on equity of 18.70% and a net margin of 10.78%. On average, analysts expect that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current year.
Reckitt Benckiser Group Increases Dividend
The company also recently announced a dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, April 10th will be given a dividend of GBX 121.70 ($1.61) per share. This represents a yield of 2.38%. The ex-dividend date of this dividend is Thursday, April 10th. This is an increase from Reckitt Benckiser Group's previous dividend of $80.40. Reckitt Benckiser Group's dividend payout ratio is currently 89.69%.
Insiders Place Their Bets
In other news, insider Kris Licht sold 3,799 shares of the business's stock in a transaction dated Friday, March 21st. The stock was sold at an average price of GBX 5,177 ($68.68), for a total value of £196,674.23 ($260,910.36). Company insiders own 0.05% of the company's stock.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
